Key result
Injection of undiluted papovavirus SV40 induced complement-fixing and neutralizing antibodies against structural antigens in all 4 monkeys, and against the T antigen in 3 monkeys.
Answers are grounded in this paper and cite their sources.
SV40 induces antibodies in monkeys; leaves open human immunogenicity, safety, and oncogenicity questions.
SummaryFour monkeys were injected with undiluted papovavirus SV40; two of them received the virus with complete Freund's adjuvant. All 4 monkeys developed both complement-fixing and neutralizing antibodies against the structural antigens of the papovavirus. Antibodies against the T antigen induced by the virus were detected in the sera from 3 of the animals. The T antibodies appeared later, attained lower levels and tended to fall earlier than the V antibodies. The specificity of the substance reacting with the T antigen was demonstrated by immunofluorescence tests with cells transformed by SV40 virus and by the SV40-adenovirus hybrid (SP2) and with human and monkey cells infected with the SP2 virus.
No takes yet. Share an insight, caveat, or question.
Vonka et al. (1967) studied Papovavirus SV40 infection (n=4). Undiluted papovavirus SV40 was evaluated on Development of complement-fixing and neutralizing antibodies against structural and T antigens. Injection of undiluted papovavirus SV40 induced complement-fixing and neutralizing antibodies against structural antigens in all 4 monkeys, and against the T antigen in 3 monkeys.
Synapse has enriched 10 related papers. Consider them for comparative context: